Immuneering Corporation

AI Score

0

Unlock

1.48
-0.17 (-10.30%)
At close: Mar 03, 2025, 3:59 PM

Immuneering Ratios Statement

Year FY23 FY22 FY21 FY20 FY19
PE Ratio -3.91 -2.6 -12.69 -26.34 -55.68
PEG Ratio -7.3 -0.05 -0.14 -0.24 n/a
PS Ratio n/a 403.77 204.62 194.16 233.78
PB Ratio 2.31 1.17 2.73 -19.96 -68.76
P/FCF Ratio -4.24 -2.85 -13.77 -30.58 -100.56
P/OCF Ratio -4.27 -2.9 -13.8 -30.7 -101.02
OCF/S Ratio n/a -139.14 -14.83 -6.33 -2.31
Debt / Equity Ratio 0.05 0.04 0.03 -0.03 -2.55
Quick Ratio 11.35 13.50 27.04 16.73 27.83
Current Ratio 11.35 13.50 27.04 16.73 27.83
Asset Turnover n/a 0.00 0.01 0.06 0.14
Interest Coverage n/a -51.01 n/a n/a -17.91
Return on Equity (ROE) -0.59 -0.45 -0.22 0.76 1.24
Return on Assets (ROA) -0.52 -0.4 -0.2 -0.44 -0.57
Return on Capital (ROIC) -0.62 -0.45 -0.21 -0.47 -0.46
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a 50.11% 44.56% 44.61% 36.29%
Net Profit Margin n/a -15.55K% -1.61K% -737.17% -419.89%
Pretax Profit Margin n/a -15.94K% -1.63K% -737.17% -401.59%
Operating Profit Margin n/a -16.33K% -1.63K% -739.01% -327.71%
FCF Margin n/a -14.15K% -1.49K% -634.83% -232.48%
EBITDA Margin n/a -16.24K% -1.62K% -735.58% -382.35%